Literature DB >> 16388325

Sequential Down syndrome screening: the importance of first and second trimester test correlations when calculating risk.

Peter Benn1, Alan E Donnenfeld.   

Abstract

Down syndrome screening can be particularly effective when both first and second trimester tests are performed. However, the counseling of women who have received sequential first and second trimester screening can be problematic. We evaluated an approximation where the post-test risk from the first trimester screening is used as the new a priori risk for the second trimester screening. The approximation disregards between-trimester test correlations. The Down syndrome detection rate based on the approximation (90.2%) would be close to that obtained when all correlations were considered (90.8%) but the false positive rate would be 26% higher (3.9% versus 3.1%, respectively). For any particular woman, the use of the approximation could result in highly inaccurate risks. We conclude that the correlations that exist between first and second trimester screening tests preclude the use of second trimester risks derived from the direct product of separate first and second trimester screening. Counseling issues in the delivery of sequential screening are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16388325     DOI: 10.1007/s10897-005-6390-7

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  14 in total

1.  Prenatal screening for Down's syndrome--a search for the family's values.

Authors:  J A Copel; R O Bahado-Singh
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

2.  First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).

Authors:  N J Wald; C Rodeck; A K Hackshaw; J Walters; L Chitty; A M Mackinson
Journal:  J Med Screen       Date:  2003       Impact factor: 2.136

3.  Antenatal screening for Down's syndrome with the quadruple test.

Authors:  Nicholas J Wald; Wayne J Huttly; Allan K Hackshaw
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

4.  Nuchal translucency and gestational age.

Authors:  Nicholas Wald; Charles Rodeck; Alicja Rudnicka; Allan Hackshaw
Journal:  Prenat Diagn       Date:  2004-02       Impact factor: 3.050

5.  Sequential pathways of testing after first-trimester screening for trisomy 21.

Authors:  Fergal D Malone
Journal:  Obstet Gynecol       Date:  2005-02       Impact factor: 7.661

6.  Practical strategies in contingent sequential screening for Down syndrome.

Authors:  Peter Benn; Dave Wright; Howard Cuckle
Journal:  Prenat Diagn       Date:  2005-08       Impact factor: 3.050

7.  Maternal serum screening for Down's syndrome in early pregnancy.

Authors:  N J Wald; H S Cuckle; J W Densem; K Nanchahal; P Royston; T Chard; J E Haddow; G J Knight; G E Palomaki; J A Canick
Journal:  BMJ       Date:  1988-10-08

8.  Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.

Authors:  N J Wald; H C Watt; A K Hackshaw
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

9.  One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.

Authors:  R Bindra; V Heath; A Liao; K Spencer; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2002-09       Impact factor: 7.299

10.  Sequential pathways of testing after first-trimester screening for trisomy 21.

Authors:  Lawrence D Platt; Naomi Greene; Anthony Johnson; Julia Zachary; Elizabeth Thom; David Krantz; Joe Leigh Simpson; Richard K Silver; Rosalinde J M Snijders; Laura Goetzl; Eugene Pergament; Karen Filkins; Maurice J Mahoney; W Allen Hogge; R Douglas Wilson; Patrick Mohide; Douglas Hershey; Scott MacGregor; Ray Bahado-Singh; Laird G Jackson; Ronald Wapner
Journal:  Obstet Gynecol       Date:  2004-10       Impact factor: 7.661

View more
  5 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 4.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 5.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.